Buy & Sell Novo Nordisk A/S (NVO) – Novo Nordisk A/S Price Today
Aura AI Summary
Key Stats
- $195.29BMarket Cap
- HealthSector
- -11.29%3M Drawdown
- $214.67BEnterprise Value
- 4.12%Dividend Yield
- 48% Buy | 52% SellTrading Activity
- 102 daysTypical Hold Time
Novo Nordisk A/S (NVO) is currently valued at a market capitalization of $195.29B, with an enterprise value of $214.67B. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $81.05, highlighting its annual price range. Over the past three months, Novo Nordisk A/S has recorded a drawdown of -11.29%, reflecting recent price volatility. Novo Nordisk A/S offers a dividend yield of 4.12%, with the most recent dividend of $1.28 paid on 30 Mar 26. On average, investors hold Novo Nordisk A/S for approximately 102 days, indicating typical investor behavior on the platform.
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Most Recent News
BlackRock surpasses 5% ownership in Finnish pharma company Orion Oyj
BlackRock, Inc. has officially notified that its direct and indirect ownership in Orion Oyj, a Finnish pharmaceutical company, has exceeded the 5% threshold as of June 4, 2026. This includes shares held directly, indirectly, and through financial ins...

DIAGNOS nears key regulatory approvals for AI eye disease detection platform CARA, expanding market potential.
DIAGNOS inc. is advancing toward important regulatory approvals for its AI-powered eye disease detection platform, CARA, with submissions underway in Canada, the US, and Saudi Arabia. The platform has already assessed over 400,000 patients globally a...

SpaceX's AI unit lost $6.4B in 2025 as it invests in massive AI infrastructure for future growth.
SpaceX's AI business reported a $6.4 billion operating loss in 2025, up from a $1.6 billion loss the previous year, reflecting heavy investment in AI compute infrastructure and growth initiatives. The company has deployed AI training clusters with ov...
